Transient elastography (TE, FibroScan ® ) is a novel non-invasive method that has been
proposed for the assessment of hepatic fibrosis in patients with chronic liver diseases, by …

Liver biopsy is required for staging hepatic fibrosis in patients with chronic hepatitis C, but it
is an expensive procedure with occasional complications and poor patient acceptance. This …

Background Interferon-containing regimens for the treatment of hepatitis C virus (HCV)
infection are associated with increased toxic effects in patients who also have cirrhosis. We …

Background & Aims The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect of …

Although spontaneous bacterial peritonitis is considered a precipitating factor of renal
impairment in cirrhosis, no study specifically addressing this problem has been reported. This …

The study of hepatitis C virus (HCV) kinetics after liver transplantation (LT) might be important
to design strategies to prevent HCV infection of the graft. We analyzed HCV kinetics during …

Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country‐specific …

Liver biopsy has long been an important tool for assessing the degree of liver fibrosis.
Information on the presence and degree of liver fibrosis is useful before making therapeutic …

Background Treatment options are limited for patients infected by hepatitis C virus (HCV) with
advanced liver disease. We assessed the safety and efficacy of ledipasvir, sofosbuvir, and …

Recurrence of hepatitis C after liver transplantation (LT) is the main cause of graft loss and
retransplantation. Frequent liver biopsies are essential to follow‐up hepatitis C virus (HCV)–…